Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-12-05

Clinical Trial Update: Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty [NA]

View source ↗

Summary

A clinical trial update comparing alpha-2 adrenergic agonists to prevent intraocular pressure elevation after selective laser trabeculoplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apraclonidine (Apraclonidine)
  • Brimonidine (brimonidine)

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Glaucoma, Ocular Hypertension | NA | Status: UNKNOWN